US Edition
Published • loading... • Updated
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMP4 Therapeutics awarded 8,000 stock options to a new hire to promote retention and align incentives under Nasdaq inducement rules.
- The Compensation Committee of the Company's Board of Directors granted a non-qualified stock option for 8,000 shares to a newly hired employee, disclosed in a recent release.
- The company is a clinical-stage biopharmaceutical developing regulatory RNA-targeting therapeutics, supporting candidate generation for over 1,200 disorders, and its RAP Platform maps regRNAs.
- The award specifies a ten-year term and an exercise price of $3.85, equal to the closing price on the Grant Date, under the Inducement Option Award Agreement CAMP4 said.
- Vesting ties the award to continued service, with 25% vesting after one year and 36 equal monthly installments, CAMP4 said.
- The Feb. 20, 2026 release notes the grant was announced in a Cambridge, Mass. press release and directs readers to camp4tx.com for more information.
Insights by Ground AI
15 Articles
15 Articles
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 22,917 restricted stock units of…
LoudounTimes.com+8 Reposted by 8 other sources
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANDOVER, Mass., Feb. 20, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on February 18, 2026, TransMedics…
Coverage Details
Total News Sources15
Leaning Left1Leaning Right1Center7Last UpdatedBias Distribution78% Center
Bias Distribution
- 78% of the sources are Center
78% Center
11%
C 78%
11%
Factuality
To view factuality data please Upgrade to Premium
